Natural Health Trends Corp. (NHTC) P/E Ratio History
Historical price-to-earnings valuation from 1998 to 2025
Loading P/E history...
NHTC Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Natural Health Trends Corp. (NHTC) trades at a price-to-earnings ratio of -41.7x, with a stock price of $3.20 and trailing twelve-month earnings per share of $-0.11.
The current P/E is 142% below its 5-year average of 100.4x. Over the past five years, NHTC's P/E has ranged from a low of 29.5x to a high of 231.4x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Consumer Cyclical sector median P/E of 19.4x, NHTC trades at a 315% discount to its sector peers. The sector includes 302 companies with P/E ratios ranging from 0.1x to 199.2x.
Relative to the broader market, NHTC trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our NHTC DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
NHTC P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $761M | 165.6 | - | +114% | |
| $8B | 108.5 | - | -29% | |
| $345M | 2.2Lowest | - | +208%Best | |
| $359M | 33.6 | - | -74% | |
| $430M | 23.2 | - | +165% | |
| $1B | 6.6 | - | -12% | |
| $1B | 23.5 | 13.74 | +25% | |
| $3B | 17.9 | 0.53Best | +2% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
NHTC Historical P/E Data (1998–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $4.33 | $0.03 | 143.4x | +93% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $5.06 | $0.04 | 115.0x | +55% |
| FY2024 Q4 | $4.62 | $0.05 | 92.8x | +25% | |
| FY2024 Q3 | Mon Sep 30 2024 00:00:00 GM | $5.95 | $0.07 | 90.6x | +22% |
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $7.10 | $0.08 | 91.4x | +23% |
| FY2024 Q1 | Sun Mar 31 2024 00:00:00 GM | $6.70 | $0.04 | 154.4x | +108% |
| FY2023 Q4 | Sun Dec 31 2023 00:00:00 GM | $5.86 | $0.05 | 118.4x | +59% |
| FY2023 Q3 | Sat Sep 30 2023 00:00:00 GM | $5.30 | $0.03 | 152.3x | +105% |
| FY2023 Q2 | Fri Jun 30 2023 00:00:00 GM | $5.53 | $0.02 | 231.4x | +211% |
| FY2023 Q1 | Fri Mar 31 2023 00:00:00 GM | $4.94 | $0.06 | 83.6x | +12% |
| FY2022 Q4 | Sat Dec 31 2022 00:00:00 GM | $3.43 | $0.03 | 125.6x | +69% |
| FY2022 Q3 | Fri Sep 30 2022 00:00:00 GM | $3.67 | $0.03 | 119.2x | +60% |
Average P/E for displayed period: 74.3x
See NHTC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NHTC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NHTC vs AMZN
Side-by-side business, growth, and profitability comparison vs Amazon.com, Inc..
Start ComparisonNHTC — Frequently Asked Questions
Quick answers to the most common questions about buying NHTC stock.
Is NHTC stock overvalued or undervalued?
NHTC trades at -41.7x P/E, below its 5-year average of 100.4x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does NHTC's valuation compare to peers?
Natural Health Trends Corp. P/E of -41.7x compares to sector median of 19.4x. The discount suggests lower growth expectations or higher risk.
What is NHTC's PEG ratio?
NHTC PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 1998-2025.